NeOnc Technologies is a biopharmaceutical company that develops oral drug treatments for primary and secondary brain cancers. Its lead products are currently undergoing early and mid-stage clinical trials to treat conditions like glioblastoma and meningioma. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?